| ID | Analyse | Domein | Recipiënt | Uitvoering ▲ | LTAT (uren (dagen)) | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 22511 | Glucose dagcurve (4pt) | Glucose (Fluoridebuis) (3×) Glucose |
84 (3,5) | – | – | – | › | |||
| 26710 | Glucose op 24 uur | 24-uurs urinecollectie |
115 (4,8) | – | – | – | › | |||
| 21687 | Glutathionperoxidase GPx | EDTA |
153 (6,4) | – | 45378-7 | – | › | |||
| 25570 | Groeihormoon-curve 10 pt. | Serum (10×) |
10 (0,4) | – | – | – | › | |||
| 25550 | Groeihormoon-curve 5 pt. | Serum (5×) |
29 (1,2) | – | – | – | › | |||
| 25590 | Groeihormooncurve ZMC | Serum (9×) |
– | – | – | › | ||||
| 8566 | Grote screening PAARD | EDTA Serum (2×) |
187 (7,8) | – | – | – | › | |||
| 22562 | GTT bij zwangere | Glucose (Fluoridebuis) (3×) |
2 (0,1) | – | – | – | › | |||
| 58620 | Hallucinogenen (o.a. LSD) | Urine |
122 (5,1) | – | 12295-2 | – | › | |||
| 23009 | Haptoglobine (vet.studie) | Serum |
– | – g/L | – | › | ||||
| 22060 | Hb chromatografie | EDTA |
62 (2,6) | – | 94537-8 | – | › | |||
| 24469 | HBsAg confirmatie Hepatitis B s Ag neutralisatie | Serum |
42 (1,8) | – | 63557-3 | – | › | |||
| 80515 | HCV confirmatie HCV kwantitatief, HCV RNA, Hepatitis C PCR | EDTA |
111 (4,6) | – | – | – | › | |||
| 80510 | HCV kwan. vermoeden kind HCV kwalitatief, HCV RNA, Hepatitis C PCR | EDTA |
– | – | – | › | ||||
| 80565 | HCV kwant. na 12 weken HCV kwantitatief, HCV RNA, Hepatitis C PCR | EDTA |
85 (3,6) | – | – | – | › | |||
| 80560 | HCV kwant. start therapie HCV kwantitatief, HCV RNA kwantitatief | EDTA (2×) |
– | – | – | › | ||||
| 80525 | HCV prikaccident HCV kwantitatief, HCV RNA, Hepatitis C PCR | EDTA |
22 (0,9) | – | – | – | › | |||
| 4796 | HE4 Human epididymis protein 4 | Serum |
166 (6,9) | – | – | – | › | |||
| 8492 | Helicobacter spp. | Varia / Diversen |
– | – | – | › | ||||
| 29230 | Hemocultuur Bloedkweek, Hemokultuur | Hemocultuur (Aéroob/anéroob) |
255 (10,6) | – | – | – | › | |||
| 22576 | Hemoglobine A1c Fast hemoglobine, Glycohemoglobine, HbA1c | EDTA |
1 (0) | – | – | – | › | |||
| 22585 | Hemoglobine A1c niet-diab Fast hemoglobine, Glycohemoglobine, HbA1c | EDTA |
1 (0) | – | 4548-4 | – | › | |||
| 80665 | Hep.B PCR kwant. HBV DNA kwantitatief, Hepatitis B PCR | EDTA |
76 (3,2) | – | – | – | › | |||
| 80535 | Hep.C PCR kwalit. HCV kwalitatief, HCV RNA, Hepatitis C PCR | EDTA |
60 (2,5) | – | – | – | › | |||
| 80575 | Hep.C PCR kwant. HCV kwantitatief, HCV RNA, Hepatitis C PCR | EDTA |
97 (4) | – | – | – | › | |||
| 80660 | Hepatit.B pcr opflakkeren HBV DNA kwantitatief, Hepatitis B PCR | EDTA |
23 (1) | – | – | – | › | |||
| 80655 | Hepatit.B PCR opvolging HBV DNA kwantitatief, Hepatitis B PCR | EDTA |
98 (4,1) | – | – | – | › | |||
| 80650 | Hepatit.B PCR voor start HBV DNA kwantitatief, Hepatitis B PCR | EDTA |
74 (3,1) | – | – | – | › | |||
| 4533 | Hepatitis E antistoffen | Serum |
14 (0,6) | – | 35680-8 | – | › | |||
| 8531 | HERDA | EDTA |
142 (5,9) | – | – | – | › | |||
| 1404 | Heredit. hemochromatose | EDTA |
– | – | – | › | ||||
| 69592 | Herpes simplex 1-2 DNA HSV 1-2 DNA | eSwab (Wissers varia / Overig) |
72 (3) | – | 91857-3 | – | › | |||
| 69632 | Herpes simplex PCR(vocht) | Varia / Diversen |
82 (3,4) | – | – | – | › | |||
| 8467 | Herpesvirus koi | Varia / Diversen |
– | – | – | › | ||||
| 57680 | Hexanol /g creatinine | Urine |
306 (12,7) | – | – | – | › | |||
| 57750 | Hippuurzuur /g creatinine | Urine |
304 (12,7) | – | – | – | › | |||
| 80690 | HIV pcr | EDTA |
92 (3,8) | – | 9836-8 | – | › | |||
| 4727 | HIV VIRALE LADING Humaan immunodeficiëntievirus virale lading | EDTA |
172 (7,2) | – | – | – | › | |||
| 7035 | Homogentisinezuur | Urine |
– | 2433-1 | – | › | ||||
| 30103 | HPV + Cytologie Cervixuitstrijkje (dunnelaag cytologie) - Preventief, Human Papillomavirus, Papsmear (dunnelaag cytologie) - Preventief | ThinPrep (Cervix- / Vloeistofcytologie) |
258 (10,7) | – | – | – | › | |||
| 30100 | HPV buiten RIZIV Human Papillomavirus | 166 (6,9) | – | – | – | › | ||||
| 30145 | HPV d1 | 333 (13,9) | – | – | – | › | ||||
| 30146 | hpv d2 | 381 (15,9) | – | – | – | › | ||||
| 89034 | HPV moleculaire Biologie | – | – | – | › | |||||
| 30127 | HPV+cyto buiten RIZIV Cervixuitstrijkje (dunnelaag cytologie) - Buiten RIZIV, Human Papillomavirus, Papsmear (dunnelaag cytologie) - Buiten RIZIV | ThinPrep (Cervix- / Vloeistofcytologie) |
245 (10,2) | – | – | – | › | |||
| 29780 | hpvabb Kwalitatieve Hoog-Risico Humaan Papillomavirus DNA L1 | – | – | – | › | |||||
| 89033 | hpvmol2 | 116 (4,8) | – | – | – | › | ||||
| 24585 | HSV type 1-2 immunoblot Herpes simplex IgG type 1, Herpes simplex IgG type 2, HSV IgG type 1-2 differentiatie | Serum |
257 (10,7) | – | 81621-5 | – | › | |||
| 4721 | HTLV (I+II) antistoffen Humaan T-Lymfotroop virus antistoffen | Serum |
107 (4,5) | – | 31431-0 | – | › | |||
| 23320 | Huid as confirmatie Basale membraan van de huid antistoffen confirmatie, Huid-antistoffen confirmatie, Keratinocyten antistoffen confirmatie | Serum |
808 (33,7) | – | – | – | › |
